A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer

Clinical trial NCT04432207 · TERMINATED

Trial details

NCT number: NCT04432207
Sponsor: Imugene Limited
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Non Small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Stage IV Squamous Non-small-cell Lung Cancer Large Cell Carcinoma Lung Adenocarcinoma Lung

Start date: 2020-11-30
Primary completion: 2024-10-08
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.